Dear Shareholders, On behalf of the board ( Board ) of directors ( Directors ) of Austar Lifesciences Limited ( Company ), I am pleased to present the annual report of the Company and its subsidiaries (collectively as the Group or AUSTAR ) for the year ended 31 December 2020 ( Year ). The year 2020 has been a challenging year for any individual, company and organization under the impact of the COVID-19 pandemic and its consequential policies. From a global perspective, the pandemic has not been slowing down even though China s pandemic conditions had become far stable and under extraordinary control. Under such conditions, the Group has been reacting, responding and acting during such extraordinary moments. Our colleagues could never have believed they were able to deliver our critical utilities and bioprocess systems to our COVID-19 vaccine manufacturer clients within 3 months from order to completion of installation and commissioning with construc
深圳试点使用在港澳上市的国外新药和医疗器械_南方网
southcn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from southcn.com Daily Mail and Mail on Sunday newspapers.
香港医生也可在深圳评职称_
timedg.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from timedg.com Daily Mail and Mail on Sunday newspapers.
深圳试点使用在港澳上市的国外新药和医疗器械 香港医生也可在深圳评职称_南方网
southcn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from southcn.com Daily Mail and Mail on Sunday newspapers.